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Abstract
Although both the α- and β-domains of intrinsic factor (IF) have been
previously expressed, the full crystal structure of the protein has yet to be
reported. The purpose of this research is to (1) express IF in order to obtain a
complete crystal structure and (2) utilize a mutant form of IF in order to
orally deliver rotavirus to the ileum. The first goal of this research is to
express IF in the yeast Pichia pastoris. The second goal is to express a K159D
IF mutant protein. K159 of IF plays a role in salt bridge formation between IF
and the CUB6 domain of cubilin, a critical receptor for vitamin B12 enterocyte
passage. The third goal is to express a Q201A IF mutant protein. Q201 of
intrinsic factor plays a role in the formation of hydrogen bonding between IF
and the CUB6 domain of cubilin. We hypothesize the mutants will either
prevent binding to cubilin or allow binding, but not allow for receptormediated endocytosis. Utilizing the vitamin B12 pathway with the K159D or
Q201A mutated IF will allow oral delivery of antigens, such as the rotavirus
vaccine, to the ileum where they can trigger an IgA immune response.
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I. Introduction
Vitamin B12 Pathway: Vitamin B12 (B12), also known as cobalamin, is a
water-soluble vitamin with a molecular weight of 1355.3 required for blood
cell formation, brain function, and DNA synthesis1. It is found in animal
products such as meat, fish, and milk1. Because of its large size, B12 is not
absorbed through the small intestine1. As a result, it requires a specific
pathway to enter the blood serum2. The B12 pathway begins when the dietary
source of B12 is broken down in the mouth (Figure 1). In the mouth it is
bound by haptocorrin (HC), which brings it through the stomach and into the
duodenum2. HC then releases B12 through the action by pancreatic proteases
and an increase in pH from about 2 to 5.51. Intrinsic factor (IF) then binds to
the B12 and brings it into the ileum3. Once in the ileum, the B12-IF complex
binds to the cubilin receptor, which is located on the surface of the intestinal
cells4. The –Cub-IF-B12 complex is then transferred across the cell through
receptor-mediated endocytosis in association with the transmembrane
protein amnionless3. Once transferred, IF is cleaved by cathepsin L and the
free B12 is picked up by transcobalamin II (TC II) and ultimately delivered to
the blood serum1.
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Figure 1. Dietary uptake pathway of B12 showing where intrinsic factor
mutation will prevent B12 endocytosis (Red “X”). (HC: haptocorrin; B12:
vitamin B12; IF: intrinsic factor; CB: cubilin; AM: amnionless).

Intrinsic Factor: IF is a glycoprotein in the vitamin B12 pathway that carries
and protects B12 during its uptake5. It consists of 399 amino acids and is 43.4
kDa in humans2. IF is produced in the gastric mucosa and secreted in the
parietal cells of the stomach1. It is composed of both an α- and β-domain and
is about 10 to 15% glycosylated2. The α-domain
domain is made up of an intertwined
helical barrel while the β-domain is made up of primarily β strands2. The two
domains are connected throug
through a short linker segment and disulfide
bridges2. IF has two separate binding domains; one for B12 and one for
cubilin1. B12 is bound where the two domains meet and is mostly shielded
from solute2. IF becomes more condensed when vitamin B12 binds to it,
allowing it to bind to cubilin2.
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Figure 2. Crystal structure of intrinsic factor missing linker between α and β
domains; Blue: α-domain, Red: β-domain, Green: Vitamin B12. Image taken
from reference 2 with permission (Alpers et. al.)
Cubilin-IF-B12 Complex: Cubilin (CUB) is the key receptor for intrinsic
factor-B12 complexes3. The binding to CUB initiates receptor-mediated
endocytosis6. The CUB5-8 domain of CUB interacts with IF-B123. The CUB6
binding site was shown to be especially important in allowing for receptormediated endocytosis to occur3. The CUB6 binding site is located on the α –
domain of IF3. This binding site involves residues from helices α-7 and α-9
and the loop region between α-5 and α-63. Both domains of IF recognize
CUB6 and CUB8 through a long, positively charged side chain which forms
electrostatic interactions with the glutamate and aspartate residues in the
binding sites of the CUB domains (Figure 3)3. The K159 of IF plays a role in
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salt bridge formation between the IF-B12 complex and cubilin3. The Q201 of
IF plays a role in hydrogen bonding with the CUB6 domain3. By mutating
these regions to decrease IF-B12 and cubilin affinity, receptor-mediated
endocytosis may be disrupted.

Figure 3. Left: CUB5–8–IF–Cbl complex. CUB (blue), IF (green), Cbl
(pink). Right: Interactions between IF and CUB6 binding domain. Image taken
from reference 3 with permission (Andersen et al.).
KM71 Pichia pastoris Cells: Pichia pastoris is a species of methylotrophic
yeast, meaning it is able to reduce carbon compounds11. It is frequently used
as an expression system for proteins because it has a high growth rate11. A
secretion signal, S. cerevisiae α factor prepropeptide, was put into P. pastoris
in order to allow the protein being expressed to be secreted into the media
rather than staying within the yeast cells12. P. pastoris has two alcohol
oxidase genes, AOX1 and AOX2, which allow P. pastoris to use methanol as an
energy source as well as an inducer12. P. pastoris metabolizes methanol
through the use of alcohol oxidases, which creates hydrogen peroxide as well
as hydroyxmethyalene13. The hydroxymethyalene is sent through cycles such
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as GAP and DHA13. In order to avoid hydrogen peroxide toxicity, peroxisomes
cleave the hydroxymethyalene to produce ½ O2 and H2O13.
KM71 P. pastoris cells were specifically chosen for the MUTs
phenotype. The MUTs phenotype means that these colonies grow slower than
the ones without the mutations, and thus can be used for selection of
colonies11. There is a slow growth phenotype because of a mutant aox1
locus11.
pPIC9: The vector used for cloning was pPIC9 (Figure 4). pPIC9 is an 8000
base pair vector containing both a 5’ and 3’ AOX1 region14. The vector is
ampicillin (amp) resistant and has multiple cloning sites14. pPIC9 is a shuttle
vector, meaning it can operate in more than one organism14. pPIC9 can be cut
by XhoI, SnaB, EcoRI, AvrII, and NotI14 and also allows for secretion of the
gene being expressed14. In order to insert at the AOX1 region, pPIC9 must be
linearized with SacI, which generates the MUTs in KM71 Pichia pastoris
cells14.
DH5α E. coli Cells: DH5α E. coli cells are chemically competent and result in
high transformation efficiency, up to 1x106 transformants/μg15. The cells are
used for efficient transformation of large plamids15.
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II. Cloning, Expression, and Purification of K159D IF Mutant

Introduction: K159 of IF plays a role in the salt bridge formation between IF
and the CUB6 domain of cubilin3. By mutating the lysine to an aspartic acid,
we hope to disrupt the salt bridge formation, and as a result, disrupt the
receptor-mediated endocytosis of IF in the B12 pathway. Changing the
positively charged lysine to a negatively charged aspartic acid should disrupt
salt bridge formation.
Site-Directed Mutagenesis: In order to create the K159D mutant, sitedirected mutagenesis was conducted. Two nucleotides from AAA were
changed to GAT, in order to mutate the K159 to an aspartic acid. A master
mix was made consisting of 0.5 μL of pfu buffer, 1 μL of dNTP, 0.37 μL FWD
primer, 0.47 μL REV primer, 1 μL of pfu turbo polymerase, 1 μL of DMSO, and
29.16 μL of dH2O. Polymerase chain reactions (PCR) mixtures of 5 ng/μL, 10
ng/μL, 25 ng/μL, and 50 ng/μL were created using 40 μL of master mix and
their respective volumes of template DNA: 1 μL, 2 μL, 5 μL, and 10 μL. Water
was added to each tube to bring the final volumes to 50 μL. The primers
(Figure 5) were designed in order to have a sequence that was the reverse
complement of the region of DNA being mutated. They were also created to
have a melting temperature between 55-65 °C.
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K159D Forward:
5’CTATCGCTGTTAGATTTGCTGATACTTTGTTGGCTAACTCCTC3’
K159D Reverse:
5’ GAGGAGTTAGCCAACAAAGTATCAGCAAATCTAACAGCG 3’
Figure 5. Forward and Reverse Primers for K159D Site Directed Mutagenesis

The PCR conditions can be seen in Table 1. The PCR was run for 18 cycles
because two nucleotides were being mutated. The annealing temperature of
62 °C was chosen by averaging the two primer melting temperatures and
subtracting 5 °C. Elongation was done at 72 °C in order for the pfu turbo
polymerase to act most efficiently.
Segment

Cycles

Temperature

Time

1

1

95 °C

30 s

18

18

95 °C

30 s

62 °C

1 min

72 °C

4 min

Table 1. PCR Setup for K159D Site-Directed Mutagenesis
After the PCR was run, 1 μL of DpnI was added to each tube in order to
get rid of the methylated parent DNA. The tubes were then incubated for 1
hour at 37 °C.
Chemical Transformation into DH5α Cells: 50 μL of chemically competent
DH5α E. coli cells were thawed on ice. 2 μL of each PCR mixture was added to
a subsequent chemically competent cell tube. The tubes were left on ice for
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30 minutes and then heat shocked at 42 °C in order to allow the plasmid to
enter the cells. 500 μL of SOC broth was added to each tube and they were
incubated for an hour at 37 °C to allow the cells to grow. Plates were
streaked with each of the mixtures and then incubated overnight at 37 °C.
The next day, there were multiple colonies on all of the plates. 10
colonies were picked and grown overnight in a shaker at 350 rpm at 37 °C in
50 mL of LB with 5 μL of ampicillin (amp). The DNA was extracted from the
cells using Wizard Plus SV Miniprep DNA Purification Method using the
centrifugation protocol. The DNA sequences of the ten colonies were
confirmed by sequencing.
Triple Digestion of pPIC9: pPIC9 was triply digested using EcoRI and NotIhf in order to open it to insert the K159D gene. Lane 1 shows the closed
vector, while Lanes 3-6 show the triply digested pPIC9 at about 8000 base
pairs (Figure 6). In order to isolate the plasmid, a gel extraction was done
using the QIAquick Gel Extraction Kit protocol.

10000 bp
8000 bp

Lane 1: Ladder
Lane 2: Control
Lanes 3-6: Triply
Digested pPIC9

Figure 6. 1% agarose gel of triply digested pPIC9.

13
Double Digested pUC57.K159D: The pUC57.K159D was doubly digested
using EcoRI and NotI-hf to open the vector. As can be seen in Figure 7, Lane 1
shows the pUC57.K159D vector. Lane 2 shows the doubly digested
pUC57.K159D. The top band is the singly cut vector, the second band is the
pUC57 vector, and the bottom band is the doubly digested K159D gene. The
singly cut vector may have occurred because more vector was present than
the enzymes could cut. The doubly digested gene (the bottom band) was
extracted using the QIAquick Gel Extraction Kit protocol.
1

2

10000 bp8000 bp-

Lane 1: Control
Lane 2: Doubly
Digested pUC57.K159D

1500 bp1200 bp-

Figure 7. 1% agarose gel of double digested pUC57.K159D.
Ligation/Transformation: A molar ligation was performed at 16 °C
overnight using molar ratios of 1:1, 3:1, 5:1, and 10:1. Then, a transformation
was performed into chemically competent DH5α cells. Ampicillin plates were
streaked and left to grow overnight at 37 °C. Eight colonies were picked for
running a diagnostic agarose gel. As can be seen in Figure 8, the gel showed a
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successful ligation in all colonies. Lanes 2-9
9 show the picked colonies. The
top band iss the pPIC9 plasmid while the bottom band is the K159D mutant
gene. Lanes 1 and 3 were confirmed by sequencing.

10000
00 bp
8000 bp

15
1500 bp
12
200 bp

Figure 8. Diagnostic 1% agarose gel showing successfull ligation of pPIC9 and
K159D.
Transformation into KM71 Cells: In order to transform into Pichia pastoris,
the plasmid must be linearized in order for a crossover to occur12. SacI was
used to linearize the DNA. As shown in Figure 9, lane 1 shows the closed
pPIC9.K159D
IC9.K159D vector whi
while lane 2 shows the linearized pPIC9.K159D vector.
The closed vector is higher because closed, circular vectors move slower on
gels than linearized DNA.

A

B

15

2000 bp1500 bp-

A. Control
B. Linearized
pPIC9

10000 bp
8000 bp

Figure 9. Linearized pPIC9.K159D cut with Sac I.
KM71 electrocompetent cells were thawed on ice. 10 μL of plasmid
DNA was added to the cells. The mixture was electroporated at 1500 volts. 1
mL of sorbitol was added to the cuvette and incubated for 1 hour at 30 °C.
The cells were streaked onto buffered media for yeast (BMY) plates and
incubated at 30 °C for five days until colonies were seen.
In order to see if the transformation was successful, a colony PCR was
run. A colony was picked and swirled into a tube containing a PCR mixture. It
was then placed in the PCR machine and sat overnight at 16 °C. As can be
seen in Figure 10, all of the colonies showed that the DNA had been
successfully inserted. However, Colony D was chosen for purification because
it was the brightest and did not have any other bands in the lane. The faint
bands at the bottom of the gel are known as primer dimer, because it is the
two primers annealing to each other rather than the DNA.
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2000 bp1500 bp-

700 bp600 bp500 bp-

Figure 10. Colony PCR of transformed KM71 Pichia pastoris cells.

K159D Expression: In order to express the K159D protein, it was first
induced in 10 mL of buffered media with glycerol for yeast (BMGY). After 18
hours, 1 mL of this culture was transferred into 600 mL of BMGY. After 16
hours the culture was centrifuged and resuspended in 200 mL of buffered
media with methanol for yeast (BMMY). This was incubated at 30 °C for 48
hours and then centrifuged. The media was then collected and filtered for
purification through the use of fast protein liquid chromatography (FPLC).
In order to find the optimum time for growth, a time course
experiment was run. 200 mL of BMMY media was incubated for 96 hours.
After every 24 hours, 1 mL of media was removed. After 96 hours, all of the 1
mL samples were run down an SDS-PAGE gel. As can be seen in Figure 11, 48
hours was the optimum time for growing the K159D mutant. After 72 hours
(Lane 8), all of the protein bands disappeared. The bands at 48 and 72 hours
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looked about the same darkness, resulting in growing the media for 48 hours
for optimum expression.
The arrows on the right in Figure 11 show the three protein bands
being looked for. The band at about 75 base pairs is glycosylated K159D,
causing it to run higher than the 43.4 kDa of IF. The band at about 45 base
pairs is unglycosylated K159D, at about the same height as unglycosylated IF.
The band at about 25 base pairs is consistent with the α-domain of the
K159D IF mutant

1.
2.
3.
4.
5.
6.
7.
8.

Ladder
PIC
Soluble
Insoluble
24 h
48 h
72 h
96 h

100 kDa
75 kDa
50 kDa
37 KDa
25 KDa

Figure 11. 12% SDS-PAGE gel of the K159D IF mutant time course over a
period of 96 hours.

K159D Purification: Fast protein liquid chromatography (FPLC) was used in
order to purify the K195D protein from the media. 150 mL of the media was
centrifuged at 8500 rpm for 1 hour at 4 °C. The media was then filtered and
injected into the FPLC. A 5 mL Histrap Ni affinity column was used with a
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binding flow rate of 1 mL/min and a binding buffer containing 1x PBS (2.7
mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4) and 0.5M NaCl. The elution flow
rate was 0.5mL/min with an elution buffer containing 1x PBS, 0.5M NaCl, and
1 M imidazole. The elution was run from 0-100% for 50 mL. The resulting
data showed two peaks in the FPLC trace, as can be seen in Figure 12.

Peak 1

Peak 2

Figure 12. FPLC trace of purified K159D showing two eluted peaks.

The corresponding SDS-PAGE gel (Figure 13) showed that peak 2
contained bands that matched up with the IF control. The first band at about
55 kDa is glycosylated K159D. The second band at about 46 kDa is
unglycosylated K159D. The third band at about 30 kDa may be the α-domain
of the intrinsic factor mutant, suggesting that some of the K159D IF is cleaved
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between the α- and β- domains during expression. This means there may be
proteases native to Pichia pastoris that can cleave IF.

1.
2.
3.
4.
5.

PIC (preinduction control)
FT (flowthrough)
Peak 1
Peak 2
IF control (2 mg/0.1 mL
10% SDS)

Figure 13. SDS-PAGE gel of FPLC purified K159D
Confirmation of K159D Mutant: A western blot was done in order to show
that K159D mutant had been expressed and purified. 750 μL of 5 mL elution
fraction samples obtained from the FPLC were trichloro acetic acid (TCA)
precipitated. Then the samples were run down a 12% SDS-PAGE gel for 90
minutes at 150 V along with an IF control (2 mg dissolved in 100 μL of 10%
SDS). The gel was stained overnight using commassie blue dye. The protein
on the SDS-PAGE gel was transferred to a membrane using the iBlot system.
The membrane was then immunoblotted using IF antibody (abcam,
abcam91322 and Santacruz, sc2370) at a 1:500 dilution. A second western
blot was also done using HisTag antibody (abcam, ab1187) at a 1:2000
dilution.

20
50 kDa

L: Ladder
37 kDa
1: crude K159D
2: eluted K159D
IF: control

50 kDa
37 kDa

Figure 14. Left: SDS-PAGE gel of membrane used for western blots; Right:
His-tag antibody western

Confocal Microscopy Uptake Studies: In order to see how the K159D
mutant interacted with cubilin in vivo, confocal microscopy uptake studies
were done. In order to prepare cultures for confocal uptake studies, purified
protein was dialyzed in 0.1 M sodium bicarbonate buffer, pH 9.0 for 24 hours
in 50 MWCO dialysis tubing. Alexa Fluor 488 was added in a 1:1 molar ration.
Alexa Fluor 488 attaches to the primary amines of protein through a TFP
ester moiety. The solution was rotated for 1 hr covered in aluminum foil. The
protein and Alexa Fluor were then dialyzed in 1 L PBS, pH 7.4 for 24 hours
three times. B12 was added in a 1:1 molar ratio and the samples were filtered
and added to 200,000 cells/mL in confocal dishes. The cells were incubated
for 45 minutes and then washed three times with PBS at pH 7.4 and three
times with PBS at pH 3.
As can be seen in Figure 15, both the IF control and K159D were
localized in the cytoplasm of the cells, indicating possible receptor-mediated
endocytosis. The BN16 cells overexpress CUB and thus the IF would be seen
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inside the cells if it is endocytosed. We had hypothesized that mutating the
K159 would disrupt receptor-mediated endocytosis, but from the confocal
uptake studies it could be seen that this was not the case. We were looking
for the K159D mutant to bind to the cubilin, but not be taken into the cells. As
can be seen n Figure 11, the K159D protein is internalized, indicating K159D
is not critical for binding despite its involvement in Ca2+ binding.

Figure 15. Right: Confocal images of IF inside BN16 cells visualized using
Alexa Fluor 488. Left: Confocal images of K159D inside BN16 cells visualized
using Alexa Fluor 488.
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III. Cloning, Expression, and Purification of Q201A Mutant IF
Introduction: Q201 of IF plays a role in the formation of hydrogen bonds
between IF and the CUB6 domain of cubilin3. By mutating a different part of
the binding site, we hope to disrupt the receptor-mediated endocytosis of IF
in the vitamin B12 pathway.
Site-Directed Mutagenesis: In order to create the Q201A mutant, sitedirected mutagenesis was done. Two nucleotides were changed in order to
mutate the Q201 to an alanine. A master mix was made consisting of 0.05 μL
of pfu buffer, 1 μL of dNTP, 0.37 μL FWD primer, 0.47 μL REV primer, 1 μL of
pfu turbo polymerase, 1 μL of DMSO, and 29.16 μL of dH2O. PCR mixtures of 5
ng/μL, 10 ng/μL, 25 ng/μL, and 50 ng/μL were created using 40 μL of master
mix and their respective volumes of template DNA: 1 μL, 2 μL, 5 μL, and 10
μL. Water was added to each tube to bring the final volumes to 50 μL. The
primers (Figure 16) were designed in order to have a sequence that was the
reverse complement of the region of DNA being mutated. The primers were
also created to have a melting temperature between 55-65 °C.
FWD Primer:
5’-GATACAGATCATTGTTCGGAGCAGTTTTGAAGGACATCGTTGA-3’
REV Primer:
5’-GTCCTTCAAAACTGCTCCGAACAATGATCTGTATCCCTC-3’
Figure 16. Forward and reverse primers for Q201A mutagenesis.

The PCR conditions can be seen in Table 2. The PCR was run for 18 cycles
because two nucleotides were being mutated. The annealing temperature of
62 °C was chosen by averaging the two primer melting temperatures and

23
subtracting 5 °C. The final stage was done at 72 °C in order for the pfu turbo
polymerase to act most efficiently.
Segment
1
18

Cycles
1
18

Temperature
95 °C
95 °C
62 °C
72 °C

Time
30 s
30 s
1 min
4 min

Table 2. PCR conditions for Q201A site-directed mutagenesis.
After the PCR was run, 1 μL of DpnI was added to each tube in order to
get rid of the methylated parent DNA. The tubes were then incubated for 1
hour at 37 °C.
Chemical Transformation into DH5α Cells: 50 μL of chemically competent
DH5α E. coli cells were thawed on ice. 2 μL of each PCR mixture was added to
a subsequent chemically competent cell tube. The tubes were left on ice for
30 minutes and then heat shocked at 42 °C in order to allow the plasmid to
enter the cells. 500 μL of SOC broth was added to each tube and they were
incubated for an hour at 37 °C to allow the cells to grow. Plates were
streaked with each of the mixtures and then incubated overnight at 37 °C.
The next day, there were multiple colonies on all of the plates. Six
colonies were picked and grown overnight at 350 rpm at 37 °C in 50 mL of
LB with 5 μL of amp. The DNA was extracted from the cells using Wizard Plus
SV Miniprep DNA Purification Method using the centrifugation protocol. The
DNA sequences of the six colonies were confirmed by sequencing.

24
Triple Digestion of pPIC9: pPIC 9 was triply digested using EcoRI and NotIhf in order to open it to insert the Q201A gene. Lane 1 shows the closed
vector, while Lanes 3-6 show the triply digested pPIC9 at about 8000 base
pairs (Figure 17). In order to isolate the plasmid, a gel extraction was done
using the QIAquick Gel Extraction Kit protocol.
Double Digested pUC57.Q201A: The pUC57.Q201A was doubly digested
using EcoRI and NotI-hf to open the vector. As can be seen in Figure 17, Lane
7 shows the pUC57.Q201A vector. Lanes 8-9 show the doubly digested
pUC57.Q201A. The first band is the pUC57 vector, and the bottom band is the
doubly digested Q201A gene. The doubly digested gene (the bottom band)
was extracted using the QIAquick Gel Extraction Kit protocol.

1. Ladder
2. pPIC9 control
3-6. Triple digested pPIC9
7. Q201A control
8-9. Double digested Q201A

2000 bp1500 bp1200 bp1000 bp-

Figure 17. 1% agarose gel of triply digested pPIC9 and double digested
pUC57.Q201A.

Ligation/Transformation: A molar ligation was performed at 16 °C
overnight using molar ratios of 1:1, 3:1, 5:1, and 10:1. Then, a transformation
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was performed into chemically competent DH5 α cells. Ampicillin plates
were streaked and left to grow overnight at 37 °C overnight. Eight colonies
were picked for running a diagnostic agarose gel. As can be seen in Figure 18,
the gel showed a successful ligation in all colonies except for colony 6. Lanes
2-9 show the picked colonies. Colony 6 showed the pPIC9 vector at a much
lower height than it should have been. The top band is the pPIC9 plasmid
while the bottom band is the K159D mutant gene. Lanes 2 and 3 were
confirmed by sequencing.

12000 bp2000 bp1500 bp1200 bp1000 bp-

Figure 18. Diagnostic gel showing successful ligation of pPIC9 plasmid and
Q201A gene in lanes D and E.
Transformation into KM71 P. pastoris Cells: In order to transform into P.
pastoris, the plasmid must be linearized in order for a crossover to occur12.
SacI was used to linearize the DNA.
KM71 electrocompetent cells were thawed on ice. 10 μL of plasmid
DNA was added to the cells. The mixture was electroporated at 1500 volts. 1
mL of sorbitol was added to the cuvette and incubated for 1 hour at 30 °C.
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The cells were streaked onto BMY plates and incubated at 30 °C for five days
until colonies were seen.
In order to see if the transformation was successful, a colony PCR was
run. A colony was picked and swirled into a tube containing a PCR mixture. It
was then placed in the PCR machine and sat overnight at 16 °C. As can be
seen in Figure 19, only colonies D and E suggested successful
transformations. Lane 1 was the control.

1

A

B

C

D E

F

G

1500 bp
1200 bp

Figure 19. Colony PCR of transformed KM71 Pichia pastoris cells.

Q201A Expression: In order to express the Q201A protein, it was first
induced in 10 mL of BMGY. After 18 hours, 1 mL of this culture was
transferred into 600 mL of BMGY. After 16 hours the culture was centrifuged
and resuspended in 200 mL of BMMY. The media was incubated at 30 °C for
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48 hours and then centrifuged. The media was then collected and filtered for
purification.
In order to find the optimum time for growth, a time course
experiment was run. 200 mL of BMMY media was incubated for 96 hours.
After every 24 hours, 1 mL of media was removed. After 96 hours, all of the 1
mL samples were run down an SDS-PAGE gel. 48 hours was the optimum
time for growing the Q201A mutant. The bands at 48 and 72 hours looked
about the same darkness, resulting in growing the media for 48 hours for
optimum expression. The bands at 96 hours look a little darker, but not
enough to increase the expression period by 48 hours.
1

2

3 4 5 6 7 8

Lane 1: Ladder
Lane 2: PIC
Lane 3: soluble
Lane 4: insoluble
Lane 5: 24h
Lane 6: 48h
Lane 7: 72h
Lane 8: 96h

Figure 20. SDS-PAGE gel of the Q201A IF mutant time course over a period
of 96 hours.
Q201A Purification: A fast protein liquid chromatography (FPLC) was used
in order to purify the Q201A protein from the media. 150 mL of the media
was centrifuged at 8500 rpm for 1 hour at 4 °C. The media was then filtered
and run down the FPLC. A 5 mL Histrap Ni affinity column was used with a
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binding flow rate of 1 mL/min and a binding buffer containing 1x PBS (2.7
mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4) and 0.5M NaCl. The elution flow
rate was 0.5mL/min with an elution buffer containing 1x PBS, 0.5M NaCl, and
1 M imidazole. A stepwise elution was done with three different percentages
of elution buffer: 4, 10, and 25 percent. The resulting data showed three
peaks as can be seen in Figure 21.
The first peak was eluted with 4% elution buffer. In the corresponding
SDS-PAGE gel, see Figure 22, there were many bands, showing that the first
peak was other stuff that had stuck to the column. The second peak was
eluted with 10% elution buffer, and had bands showing the correct height for
the IF mutant. The third peak was eluted with 25% elution buffer and did not
show any bands on the SDS-PAGE with commassie staining.

Figure 21. FPLC trace of Q201A stepwise elution.
Confirmation of Q201A Mutant: A western blot was conducted in order to
show that the Q201A mutant had been expressed and purified. 750 μL of 5
mL elution fraction samples obtained from the FPLC were TCA precipitated.
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Then the samples were run down a 12% SDS-PAGE gel for 90 minutes at 150
V along with an IF control (2 mg dissolved in 100 μL of 10% SDS). The gel
was stained overnight using commassie blue dye. Western blots were also
performed on the samples obtained from the FPLC. The protein on the SDSPAGE gel was transferred to a membrane using the iBlot. The membrane was
then immunoblotted using HisTag antibody (abcam, ab1187) at a 1:2000
dilution.
As can be seen in Figure 22, bands at about 46 kDa appeared on the
western blot in both the 4% elution and 10% elution peaks. In the 10%
(lanes 8-10), the α fragment can also be seen at about 25 kDa.

1 2 3 4 5 6
9

Lane 1: PIC
Lane 2: FT
Lane 3: Ladder
Lane 4-6:4%
Lane 7-10: 10%
Lane 11-12: 25%

50 kDa45 kDa-

1 2 3 4 5 6 7 8 9 101112
9

7 8 9 10 11 12

50 kDa37 kDa-

25 kDa-

Figure 22. Left: SDS-PAGE gel of FPLC peaks of Q201A Right: His-tag western
blot of Q201A
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IV. Conclusion
In the future, the K159D confocal micrscopy has to be redone. Also,
the Q201A confocal micrscopy has to be done. The IF, K159D, and Q201A
proteins are being tested for specific cubilin binding in collaboration with
Professor Mette Madsen, University of Aarhus, Denmark. Professor
Madsens’s lab will look at the specific binding affinities between each of the
mutants and cubilin, allowing us to compare them quantitatively rather than
just through images on the confocal.
Research on the K159D and Q201A mutants will help to shed light on
important intrinsic factor binding sites. By binding rotavirus to the mutants,
a safer alternative to the current vaccine may be created, leading to better
third-world access to the drug. Finally, utilizing the B12 uptake pathway in
this way, it could become a delivery system for other vaccines, offering a new
platform for drug delivery.
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Capstone Summary
The vitamin B12 pathway is an important delivery mechanism for the
body to absorb B125. Food containing B12, such as meat, is broken down in
the mouth where the B12 is then picked up by the transport protein
haptocorrin (HC)5. The HC-B12 complex goes through the stomach and HC is
broken down by a change in pH and proteases5. B12 is picked up by IF and
brought into the small intestine. The IF-B12 complex is then bound to cubilin
(CUB) and transported into the epithelial cells of the small intestine3. The
B12 is eventually delivered into the blood serum3.
In order to use this pathway for drug delivery, we had to create a
mutant form of IF that would bind to cubilin but not enter the cell. This way,
the drug would stay localized in the small intestine to trigger an immune
response. It has been shown that the CUB5-8 binding domains are important
for transporting the IF-B12 into the cell, especially the CUB6 and CUB8
domains3. We examined the binding between the CUB6 domain of cubilin and
IF and distinguished two amino acids that could be changed to disrupt
binding. The first mutation was a K159D mutant, which changed the lysine of
IF to an aspartic acid. This would disrupt salt bridge formation between
cubilin and IF. The other mutation was a Q201A mutant, which changed the
glutamine to an alanine. This would disrupt hydrogen bonding between
cubilin and IF.
A site-directed mutagenesis was done in order to create both the
K159D and Q201A mutants. Site-directed mutagenesis is a procedure in
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which a specific area of a DNA molecule is mutated. The IF DNA molecule
was mixed with primers containing the mutations we were trying to create in
the IF protein. A polymerase chain reaction (PCR) was run in order for the
primers to bind to the IF DNA molecule and make many copies of it that
contained the mutations. The original non-mutated IF DNA was removed
through the use of the enzyme DpnI, which gets rid of methylated DNA. We
confirmed the correct mutations were made and that no other mutations had
occurred during the process by sending off the samples for sequencing.
Next, we needed to express both the K159D and Q201A mutants so
that we could get enough of each for experiments. This was done through the
use of Pichia pastoris, a yeast. The K159D and Q201A mutants were placed
inside the yeast cells through the use of a vector. As the yeast grew, it also
secreted the mutant proteins into the media.
The IF mutants were expressed in Pichia pastoris cells, which are
yeast cells. The DNA was inserted into the cells and grown up in media, while
also secreting the IF mutants into the media. However, the protein is mixed
in with all of the nutrients and other things the yeast is secreting while
growing. As a result, we had to purify the media in order to collect only the
protein. This was done through the use of fast protein liquid chromatography
(FPLC). The media is injected into the FPLC and run through a nickel affinity
column. Both of the IF mutants are tagged with six histidine residues at the
end of their amino acid chains, allowing them to bind to the nickel column
while everything else is flushed away. In order to collect the protein, the
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column is washed with a buffer containing imidazole. Imidazole has a similar
structure to histidine; allowing it to bind to the nickel column and in the
process, knock off the IF mutants.
In order to ensure we were expressing and purifying the correct
proteins, we ran two experiments to examine the samples. The first method
we used was running an SDS-PAGE gel. The SDS-PAGE gel separates proteins
based on their size. By running our samples on the gel along with an IF
control, we were able to compare the bands of our protein to the band of the
IF protein. IF is about 45 kDa and the mutants should appear at the same
height, as one amino acid switch will not affect its size by very much. Both
proteins showed up at the correct heights. However, there was also a higher
band at about 55 kDa and a lower band at about 30 kDa. The 55 kDa band is
glycosylated IF, meaning it has had sugars added to it, while the lower band
is the α domain of IF.
The other test that we performed on the purified samples was a
western blot. Another SDS-PAGE gel was run and the protein bands were
transferred to a membrane. Antibodies specific to IF are washed over the
membrane and bind to anything with the IF binding site for the antibody. A
second antibody is washed over the membrane that will bind to the first
antibody to enhance the signal. These sites are then detected by spraying a
luminescent solution over the membrane and then transferring it to a film.
The film is developed and the resulting bands can be seen on it. As with the
SDS-PAGE gel, an IF control was run with the samples so that we could
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compare bands. As with the SDS-PAGE gel, the bands matched and also
ensured that the IF mutants were being created, as the antibodies are specific
only to IF.
Confocal studies allowed us to see how the mutants interacted with
cubilin. The K159D protein was dyed green so that we could track their
interactions with BN16 cells, which overexpress cubilin. Preliminary
experiments showed that the protein entered the cell, which is not what we
had attempted to do. As previously mentioned, we had wanted to stop the
proteins from entering the cells.
However, future work entails redoing this experiment with both
mutants as well as sending off samples to a lab in Denmark. They will look at
the specific binding affinities between each of the mutants and cubilin,
allowing us to compare them quantitatively rather than just through images
on the confocal.
Research on the K159D, Q201A, and K159D Q201A mutants will help
to shed light on important intrinsic factor binding sites. By binding rotavirus
to the mutants, a safer alternative to the current vaccine may be created,
leading to better third-world access to the drug. Finally, utilizing the B12
uptake pathway in this way, it could become a delivery system for other
vaccines, offering a new platform for drug delivery.

